Cargando…

Supercritical fluid-mediated liposomes containing cyclosporin A for the treatment of dry eye syndrome in a rabbit model: comparative study with the conventional cyclosporin A emulsion

BACKGROUND: The objective of this study was to compare the efficacy of cyclosporin (CsA)-encapsulated liposomes with the commercially available CsA emulsion (Restasis(®)) for the treatment of dry eye syndrome in rabbits. METHODS: Liposomes containing CsA were prepared by the supercritical fluid (SCF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karn, Pankaj Ranjan, Kim, Hyun Do, Kang, Han, Sun, Bo Kyung, Jin, Su-Eon, Hwang, Sung-Joo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134020/ https://www.ncbi.nlm.nih.gov/pubmed/25143728 http://dx.doi.org/10.2147/IJN.S65601

Ejemplares similares

Preparation and evaluation of cyclosporin A-containing proliposomes: a comparison of the supercritical antisolvent process with the conventional film method
por: Karn, Pankaj Ranjan, et al.
Publicado: (2014)

Characterization and stability studies of a novel liposomal cyclosporin A prepared using the supercritical fluid method: comparison with the modified conventional Bangham method
por: Karn, Pankaj Ranjan, et al.
Publicado: (2013)

Comparative analysis of 0.1% cyclosporin A cationic emulsion and 0.05% cyclosporin A emulsion in murine dry eye cases with different severities
por: Jin, Rujun, et al.
Publicado: (2021)

Efficacy of Topical Cyclosporine Nanoemulsion 0.05% Compared with Topical Cyclosporine Emulsion 0.05% and Diquafosol 3% in Dry Eye
por: Park, Chang Hyun, et al.
Publicado: (2019)

Cyclosporine Amicellar delivery system for dry eyes
por: Kang, Han, et al.
Publicado: (2016)

Dry Eye Treatment with Topical Cyclosporine 0.1% in Chondroitin Sulfate Ophthalmic Emulsion
por: Matossian, Cynthia, et al.
Publicado: (2021)

Treatment of chronic dry eye: focus on cyclosporine
por: Kymionis, George D, et al.
Publicado: (2008)

Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients
por: Stonecipher, Karl G, et al.
Publicado: (2013)

Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye
por: Deveney, Tatiana, et al.
Publicado: (2018)

Safety and Efficacy of Cyclosporine in the Treatment of Chronic Dry Eye
por: Schultz, Clyde
Publicado: (2014)

Cyclosporine 0.05% Ophthalmic Emulsion for Dry Eye in Korea: A Prospective, Multicenter, Open-Label, Surveillance Study
por: Byun, Yong-Soo, et al.
Publicado: (2011)

Drug-eluting contact lens containing cyclosporine-loaded cholesterol-hyaluronate micelles for dry eye syndrome
por: Mun, Jonghwan, et al.
Publicado: (2019)

Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye
por: White, Darrell E, et al.
Publicado: (2019)

Preparation, Characterization, and In Vivo Pharmacokinetic Study of the Supercritical Fluid-Processed Liposomal Amphotericin B
por: Lim, Chang-baek, et al.
Publicado: (2019)

An Overview on Dry Eye Treatment: Approaches for Cyclosporin A Delivery
por: Yavuz, Burçin, et al.
Publicado: (2012)

The Effects of Fisetin on Cyclosporine-Treated Dry Eye Disease in Dogs
por: Krajčíková, Kristína, et al.
Publicado: (2023)

Comparison of topical cyclosporine alone and topical loteprednol with cyclosporine in moderate dry eye in Indian population: A prospective study
por: Singla, Shaveta, et al.
Publicado: (2019)

A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments
por: Periman, Laura M, et al.
Publicado: (2020)

Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease
por: Burade, Vinod, et al.
Publicado: (2020)

One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease
por: Baudouin, Christophe, et al.
Publicado: (2017)

Cyclosporine reduces the spleen dimensions in rabbits
por: Alberti, Luiz Ronaldo, et al.
Publicado: (2021)

Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt
por: Guan, Peipei, et al.
Publicado: (2011)

A Randomized Study of the Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in Treatment of Moderate to Severe Dry Eye
por: Baudouin, Christophe, et al.
Publicado: (2017)

Comparison of Consecutive Therapeutic Effects of Nanoemulsion and Emulsion Cyclosporin in Dry Eye Patients after Short-Term Treatment with Topical Fluorometholone
por: Choi, Yeon Sun, et al.
Publicado: (2022)

Real-World Effectiveness, Tolerability and Safety of Cyclosporine A 0.1% Cationic Emulsion in Severe Keratitis and Dry Eye Treatment
por: Geerling, Gerd, et al.
Publicado: (2022)

Assessment of the efficacy of 0.1% cyclosporine A cationic emulsion in the treatment of dry eye disease during COVID-19 pandemic
por: Stopyra, Wiktor
Publicado: (2023)

Short Term Effects of Topical Cyclosporine and Viscoelastic on the Ocular Surfaces in Patients with Dry Eye
por: Moon, Jun Woong, et al.
Publicado: (2007)

Efficacy and safety of topical cyclosporine 0.1% in moderate-to-severe dry eye disease refractory to topical cyclosporine 0.05% regimen
por: Chan, Yuan-Hsi, et al.
Publicado: (2023)

Cyclosporine Lipid Nanocapsules as Thermoresponsive Gel for Dry Eye Management: Promising Corneal Mucoadhesion, Biodistribution and Preclinical Efficacy in Rabbits
por: Eldesouky, Lubna M., et al.
Publicado: (2021)

The Effect of Topical Cyclosporine 0.05% on Dry Eye after Cataract Surgery
por: Chung, Yeon Woong, et al.
Publicado: (2013)

Once-Daily Cyclosporine-A-MiDROPS for Treatment of Dry Eye Disease
por: Coursey, Terry G, et al.
Publicado: (2018)

Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease
por: de Oliveira, Rodrigo Carlos, et al.
Publicado: (2019)

Cyclosporine (0.05%) Combined with Diclofenac Sodium Eye Drops for the Treatment of Dry Eye Disease
por: Bai, Run, et al.
Publicado: (2022)

Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit model
por: Liang, Hong, et al.
Publicado: (2012)

PERSIST: Physician’s Evaluation of Restasis(®) Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review
por: Mah, Francis, et al.
Publicado: (2012)

Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature
por: Rhee, Michelle K, et al.
Publicado: (2017)

Topical Cyclosporine A for Treatment of Dry Eye Due to Chronic Mustard Gas Injury
por: Jadidi, Khosrow, et al.
Publicado: (2014)

Incidence and management of symptomatic dry eye related to LASIK for myopia, with topical cyclosporine A
por: Kanellopoulos, Anastasios John
Publicado: (2019)

Comparison of matrix metallopeptidase-9 expression following cyclosporine and diquafosol treatment in dry eye
por: So, Ha Rim, et al.
Publicado: (2023)

A Prospective Study of Cyclosporine A 0.1% Combined with Loteprednol 0.2% vs Cyclosporine A 0.05% Alone in the Treatment of Dry Eye
por: Hovanesian, John, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fl48eoak16fk888hdvr1tml5sn